Certain shares of Northwest Biotherapeutics, Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 5-JAN-2014. These shares will be under lockup for 45 days starting from 21-NOV-2013 to 5-JAN-2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4489 USD | -0.34% |
|
-4.39% | -35.96% |
10/05 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
21/03 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-35.96% | 55Cr | |
+16.45% | 12TCr | |
+21.96% | 11TCr | |
+23.73% | 2.59TCr | |
-20.05% | 2.09TCr | |
-16.28% | 1.68TCr | |
-16.52% | 1.65TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.55TCr | |
+2.52% | 1.34TCr |
- Stock Market
- Equities
- NWBO Stock
- News Northwest Biotherapeutics, Inc.
- Certain shares of Northwest Biotherapeutics, Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 5-JAN-2014.